Indoco Remedies Ltd. Share Price & Stock Analysis

Indoco Remedies Ltd. (NSE: INDOCO, BSE: 532612) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹2,026 Cr, it ranks #1,235 by market cap among the 6,197 Indian listed companies on FinBizNet, and #36 of 86 in Medicinal Chemicals and Botanical Products. At ₹227.30 (as of 16 Nov 2026), the share price is 21.0% below its 52-week high of ₹287.80 and 40.1% above its 52-week low of ₹162.19. The share price is down 12.4% over one year and up 2.9% over three months.

Key Metrics

Current Price₹227.30
Market Cap₹2,026 Cr
NSE SymbolINDOCO
BSE Code532612
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E RatioNot meaningful (loss)
Return on Equity-10.12%
Return on Assets0.40%
52-Week Range₹162.19 – ₹287.80
1-Year Price Change-12.4%
3-Month Price Change+2.9%
Beta (1Y)0.36
Dividend Yield0.09%
HeadquartersMumbai, Maharashtra
Websitewww.indoco.com

Latest Quarterly Results — Q2 FY27

Revenue₹520 Cr
Net Profit₹19 Cr
Net Margin3.7%
EPS (Basic)₹2.11
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Indoco Remedies Ltd. Quarterly Revenue and Profit Trend

Indoco Remedies Ltd. reported revenue of ₹520 Cr in Q2 FY27, up 7.3% from ₹485 Cr in Q2 FY26 and up 11.3% from ₹468 Cr in Q1 FY27. It posted a net profit of ₹19 Cr for the quarter, against a net loss of ₹9 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹390 Cr (Q4 FY25) to ₹520 Cr (Q2 FY27). The company reported a net loss in 5 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹520 Cr₹19 Cr3.7%
Q1 FY27₹468 Cr₹65 Cr14.0%
Q4 FY26₹476 Cr−₹24 Cr−5.0%
Q3 FY26₹445 Cr−₹29 Cr−6.6%
Q2 FY26₹485 Cr−₹9 Cr−1.9%
Q1 FY26₹438 Cr−₹36 Cr−8.3%
Q4 FY25₹390 Cr−₹41 Cr−10.6%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 58.92% of Indoco Remedies Ltd.'s shares as of Sept 2026, against 58.90% in Sept 2025 (+0.02 percentage points). Delivery averaged 45.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Indoco Remedies Ltd.

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and valid

Products and Services

1. Pharmaceuticals-This segment manufactures and sells formulations and active pharmaceutical ingredients.

Business Segments

1. Pharmaceuticals-100%

Indoco Remedies Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Indoco Remedies Ltd.₹2,026 Crn/m-10.12%₹520 Cr-12.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Indoco Remedies Ltd.?

Indoco Remedies Ltd. is trading at ₹227.30, with a market capitalisation of ₹2,026 Cr.

Which sector does Indoco Remedies Ltd. belong to?

Indoco Remedies Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Indoco Remedies Ltd.?

Indoco Remedies Ltd. has a return on equity of -10.12%.

What is the stock symbol of Indoco Remedies Ltd.?

Indoco Remedies Ltd. is listed on the NSE under the symbol INDOCO and on the BSE under the scrip code 532612.

How has Indoco Remedies Ltd.'s share price moved over the past year?

Indoco Remedies Ltd.'s share price is down 12.4% over one year and up 2.9% over three months. Its 52-week range is ₹162.19 to ₹287.80.

What were Indoco Remedies Ltd.'s latest quarterly results?

In Q2 FY27, Indoco Remedies Ltd. reported revenue of ₹520 Cr and net profit of ₹19 Cr, with basic EPS of ₹2.11 (consolidated, parsed from the company's exchange filing).

How have Indoco Remedies Ltd.'s revenue and profit changed over the past year?

Indoco Remedies Ltd. reported revenue of ₹520 Cr in Q2 FY27, up 7.3% from ₹485 Cr in Q2 FY26 and up 11.3% from ₹468 Cr in Q1 FY27.

What is the promoter holding in Indoco Remedies Ltd.?

Promoters held 58.92% of Indoco Remedies Ltd.'s shares as of Sept 2026, against 58.90% in Sept 2025 (+0.02 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.